Malawi - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Malawi Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases decreased by 0.4% year on year. In 2019, the country was number 133 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 104 Cases. Malawi is overtaken by United States, which was number 132 at 105 Cases and is followed by Armenia with 103 Cases. India lead the ranking with 66,255 Cases in 2019, that is a growth of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 104.00 |
| 2018 | 126.00 |
| 2017 | 85.00 |
| 2016 | 66.00 |
| 2015 | 93.00 |
How does Malawi rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 127 |
#127
Bolivia
|
126 | 2019 | +14.6 % | +2.8 % | View data | |
| 133 |
#133
Malawi
|
104 | 2019 | -17.5 % | -0.4 % | View data | |
| 134 |
#134
Armenia
|
103 | 2019 | -1.9 % | -1.5 % | View data | |